Jupiter Life Line Hospitals announces a Rs.1 interim dividend for Q4 FY26, along with a 1:5 stock split. Notably, the board also made strategic management appointments.

Jupiter Life Line Hospitals reported a 16% increase in Q4 EBITDA, reaching ₹907 million, while the EBITDA margin dipped slightly to 23.4%. Despite this marginal decrease, the hospital network's overall profitability remains robust.

Jupiter Life Hospitals surpasses expectations in FY26, reporting a revenue increase of 15.3% to INR 1,435 crores. The earnings before interest, taxes, depreciation, and amortization (EBITDA) stood at INR 343.3 crores, yielding a margin of 23%. However, the Dombivli hospital had an impact on Q4 costs.

The Jupiter Life BKC hospital unit in Mumbai is expected to benefit from robust pricing, potentially leading to growth due to favorable market conditions in the city.